If you want the option to choose between compounded and branded medications, Hims gives you flexibility
AARP Membership Join AARP for only $15 per year with automatic renewal
Even those with moderate weight challenges or weight-related health risks can benefit from these treatments
Found Health's terms identify multiple affiliated entities including Pippen Health of California, P.C., Pippen Health of Texas, P.A., Pippen Health of Delaware, P.A., Cloud Health Medical Group, P.A., and Adept Labs, Inc
Cash-pay telehealth weight loss was the early model (companies like Ro, Hims, Calibrate): Monthly membership fee ($50-200) Plus cost of medication (either marked up through compounding pharmacies or retail GLP-1s) Patients pay out of pocket entirely Pros: No insurance billing hassle Higher margins per patient if you mark up medications Cons: Limited to affluent patients High churn when patients cant afford $300-500/month ongoing Regulatory scrutiny (many compounded semaglutide products were investigated for safety) Insurance-based model is becoming more viable: Bill insurance for visits (E/M codes) Send GLP-1 prescription to patients pharmacy (they use insurance for medication) You get paid per visit (~$100-150), patient pays copay Pros: Larger addressable market (anyone with obesity diagnosis and insurance) More sustainable (patients can afford to stay on therapy long-term) Less regulatory risk (using FDA-approved products through licensed pharmacies) Cons: Prior authorization burden Payment delays from insurers Need credentialing with multiple payers Hybrid approach: Some practices bill insurance when possible, offer cash-pay as backup for patients with exclusions
Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved for type 2 diabetes management but may be prescribed off-label for weight management at a clinician's discretion
